A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 331 participants.
Also called NCT01614652
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 331 participants
- Sponsor
- CardioKinetix, Inc
- Registry
-
NCT01614652
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01614652. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2017-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
- Acronym
- PARACHUTE IV
- Condition
- Congestive Heart Failure
- Condition
- Left Ventricular (LV) Systolic Dysfunction
- Intervention (Device)
- CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
- Lead sponsor
- CardioKinetix, Inc
Record details
- Record id
cardio:ct-nct01614652- Content hash
1a0eda6f05b193c6416f752846d8bf4efc5ed763095d56a14bd8ece99597b214